- Home
- TTOO vs MRNS Comparison
TTOO vs MRNS Comparison
Compare TTOO & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTOO
- MRNS
- Stock Information
- Founded
- TTOO 2006
- MRNS 2003
- Country
- TTOO United States
- MRNS United States
- Employees
- TTOO N/A
- MRNS N/A
- Industry
- TTOO Medical/Dental Instruments
- MRNS Biotechnology: Pharmaceutical Preparations
- Sector
- TTOO Health Care
- MRNS Health Care
- Exchange
- TTOO Nasdaq
- MRNS Nasdaq
- Market Cap
- TTOO 36.4M
- MRNS 104.7M
- IPO Year
- TTOO 2014
- MRNS 2014
- Fundamental
- Price
- TTOO $0.97
- MRNS $0.31
- Analyst Decision
- TTOO Hold
- MRNS Buy
- Analyst Count
- TTOO 1
- MRNS 12
- Target Price
- TTOO $5.00
- MRNS $4.56
- AVG Volume (30 Days)
- TTOO 710.5K
- MRNS 5.7M
- Earning Date
- TTOO 11-13-2024
- MRNS 11-05-2024
- Dividend Yield
- TTOO N/A
- MRNS N/A
- EPS Growth
- TTOO N/A
- MRNS N/A
- EPS
- TTOO N/A
- MRNS N/A
- Revenue
- TTOO $7,164,000.00
- MRNS $30,263,000.00
- Revenue This Year
- TTOO $50.31
- MRNS $21.18
- Revenue Next Year
- TTOO $117.92
- MRNS $56.42
- P/E Ratio
- TTOO N/A
- MRNS N/A
- Revenue Growth
- TTOO N/A
- MRNS 16.56
- 52 Week Low
- TTOO $0.90
- MRNS $0.26
- 52 Week High
- TTOO $8.38
- MRNS $11.26
- Technical
- Relative Strength Index (RSI)
- TTOO 18.34
- MRNS 21.75
- Support Level
- TTOO $0.90
- MRNS $0.29
- Resistance Level
- TTOO $1.86
- MRNS $1.96
- Average True Range (ATR)
- TTOO 0.15
- MRNS 0.12
- MACD
- TTOO -0.00
- MRNS -0.18
- Stochastic Oscillator
- TTOO 5.72
- MRNS 2.41
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.